ValiRx plc

LSE (GBp): ValiRx plc (VAL)

Last Price

0.38

Today's Change

+0.055 (16.92%)

Day's Change

0.32 - 0.38

Trading Volume

12,754,795

Overview

Market Cap

1 Million

Shares Outstanding

374 Million

Avg Volume

9,178,763

Avg Price (50 Days)

0.38

Avg Price (200 Days)

0.52

PE Ratio

-0.38

EPS

-0.01

Earnings Announcement

10-Jun-2026

Previous Close

0.33

Open

0.33

Day's Range

0.32 - 0.38

Year Range

0.22 - 1.0

Trading Volume

12,754,795

Price Change Highlight

1 Day Change

16.92%

5 Day Change

26.67%

1 Month Change

61.70%

3 Month Change

-49.33%

6 Month Change

-15.56%

Ytd Change

-49.33%

1 Year Change

-50.97%

3 Year Change

-96.83%

5 Year Change

-98.43%

10 Year Change

-99.98%

Max Change

-100.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer. Its drug candidates also comprise VAL301, a peptide ingredient that in pre-clinical development for the treatment of women with endometriosis; and BC201, a combination of the peptide ingredient of VAL201/VAL301 with complementary active components for the treatment for patients suffering severe symptoms of Covid-19. ValiRx plc was incorporated in 2000 and is based in Hatfield, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment